0001771623-19-000001.txt : 20190906
0001771623-19-000001.hdr.sgml : 20190906
20190906094845
ACCESSION NUMBER: 0001771623-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190906
DATE AS OF CHANGE: 20190906
EFFECTIVENESS DATE: 20190906
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valanbio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771623
IRS NUMBER: 473852677
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-348130
FILM NUMBER: 191078654
BUSINESS ADDRESS:
STREET 1: 1120 LONGSTONE WAY
CITY: RALEIGH
STATE: NC
ZIP: 27614
BUSINESS PHONE: 919-360-7010
MAIL ADDRESS:
STREET 1: 1120 LONGSTONE WAY
CITY: RALEIGH
STATE: NC
ZIP: 27614
D
1
primary_doc.xml
X0708
D
LIVE
0001771623
Valanbio Therapeutics, Inc.
1120 LONGSTONE WAY
RALEIGH
NC
NORTH CAROLINA
27614
919-360-7010
DELAWARE
None
None
Corporation
true
2015
Clayton
Duncan
c/o Valanbio Therapeutics, Inc.
1120 Longstone Way
Raleigh
NC
NORTH CAROLINA
27614
Executive Officer
Director
Sam
Hopkins
c/o Valanbio Therapeutics, Inc.
1120 Longstone Way
Raleigh
NC
NORTH CAROLINA
27614
Director
Eric
J.
Toone
c/o Valanbio Therapeutics, Inc.
1120 Longstone Way
Raleigh
NC
NORTH CAROLINA
27614
Director
Pei
Zhou
c/o Valanbio Therapeutics, Inc.
1120 Longstone Way
Raleigh
NC
NORTH CAROLINA
27614
Executive Officer
Director
Moise
A.
Khayrallah
c/o Valanbio Therapeutics, Inc.
1120 Longstone Way
Raleigh
NC
NORTH CAROLINA
27614
Executive Officer
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2018-08-27
true
true
false
7000
275000
121000
154000
false
4
0
0
0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
false
Valanbio Therapeutics, Inc.
/s/ Clayton Duncan
Clayton Duncan
Chief Executive Officer
2019-09-05